FDA Inspection
Cambrex Charles City, Inc.Cambrex Charles City, Inc. – FDA Inspection, Aug 2, 2013
Record Details
This FDA Inspection record concerns Cambrex Charles City, Inc., with an inspection on August 2, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cambrex Charles City, Inc.
- Inspection Date
- August 2, 2013
- Product Type
- Drugs
View Company Profile
ID · 147242f0-cce7-4513-bca0-cfa211d9eb76
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 843001
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cambrex Charles City, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Kansas City District Office | |
| May 2, 2022 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 22, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 27, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cambrex Charles City, Inc.
- FDA Inspection 1266564 - 2025-03-07
- FDA Inspection 1169072 - 2022-05-02
- FDA Inspection 1009802 - 2016-12-22
- FDA Inspection 868083 - 2014-02-27
- FDA Inspection 768805 - 2012-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.